Emerging roles of plasma gelsolin in tumorigenesis and modulating the tumor microenvironment
Authors:
Open Access
- 9 August 2022
- journal article
- review article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 38 (9) , 819-825
Abstract
The protein expression of gelsolin, an actin scavenger controlling cytoskeletal remodeling, cell morphology, differentiation, movement, and apoptosis, has been found to be significantly decreased in several pathological conditions including neurodegenerative diseases, inflammatory disorders, and cancers. Its extracellular isoform, called plasma gelsolin (pGSN), is one of the most abundant plasma proteins in the circulation, and has emerged as a novel diagnostic biomarker for early disease detection. Current evidence reveals that gelsolin can function as either an oncoprotein or a tumor suppressor depending on the carcinoma type. Interestingly, recent studies have shown that pGSN is also involved in immunomodulation, revealing the multifunctional roles of pGSN in tumor progression. In this review, we discuss the current knowledge focusing on the roles of gelsolin in inflammation and wound healing, cancers, and tumor microenvironment. Future prospects of pGSN related studies and clinical application are also addressed.Keywords
This publication has 66 references indexed in Scilit:
- Gelsolin Induces Colorectal Tumor Cell Invasion via Modulation of the Urokinase-Type Plasminogen Activator CascadePLOS ONE, 2012
- Knockdown of HMGB1 in Tumor Cells Attenuates Their Ability To Induce Regulatory T Cells and Uncovers Naturally Acquired CD8 T Cell-Dependent Antitumor ImmunityThe Journal of Immunology, 2011
- Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrinJournal of Cellular and Molecular Medicine, 2011
- Plasma gelsolin modulates cellular response to sphingosine 1-phosphateAmerican Journal of Physiology-Cell Physiology, 2010
- Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritisArthritis Research & Therapy, 2008
- PKCε is essential for gelsolin expression by histone deacetylase inhibitor apicidin in human cervix cancer cellsBiochemical and Biophysical Research Communications, 2007
- Plasma gelsolin is a marker and therapeutic agent in animal sepsis*Critical Care Medicine, 2007
- Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motilityGut, 2007
- Inactivation of Endotoxin by Human Plasma GelsolinBiochemistry, 2005
- Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10British Journal of Cancer, 2003